Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells

Madhumitha Kedhari Sundaram1, Sreepoorna Unni2, Pallavi Somvanshi3

  • 1School of Life Sciences, Manipal Academy of Higher Education, P.O. Box 345050 Dubai, United Arab Emirates.

Genes
|November 27, 2019
PubMed
Abstract

Insights

Genistein, a phytochemical, reverses epigenetic changes and restores tumor suppressor gene expression in HeLa cells. This suggests genistein

Area of Science:

  • Epigenetics and Molecular Oncology
  • Phytochemicals and Cancer Therapeutics

Background:

  • Epigenetic alterations drive carcinogenesis by modifying signaling pathways and tumor suppressor genes (TSGs).
  • HeLa cells are utilized to investigate the molecular effects of genistein, a plant-derived compound.

Purpose of the Study:

  • To investigate the impact of genistein on molecular targets involved in cancer.
  • To elucidate the epigenetic mechanisms underlying genistein's anti-cancer effects.

Main Methods:

  • Quantitative PCR (qPCR) for gene expression analysis.
  • Biochemical assays for epigenetic enzyme activity.
  • Quantitative methylation array and methylation-specific restriction digestion for promoter methylation analysis.

Main Results:

  • Genistein modulated genes in cell cycle, migration, inflammation, PI3K, and MAPK pathways.
  • Genistein altered the expression and activity of epigenetic modifiers, including DNA methyltransferases (DNMTs) and histone deacetylases (HDACs).
  • Genistein reduced global DNA methylation and specific TSG promoter methylation, leading to increased gene transcription.

Conclusions:

  • Genistein exhibits anti-cancer potential through comprehensive epigenetic modulation and transcriptional restoration of TSGs.
  • The findings support genistein's development as a therapeutic candidate for cancer treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K